These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9464567)

  • 1. Molecular modeling of interleukin-8 receptor beta and analysis of the receptor-ligand interaction.
    Luo Z; Butcher DJ; Huang Z
    Protein Eng; 1997 Sep; 10(9):1039-45. PubMed ID: 9464567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
    Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
    J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.
    Skelton NJ; Quan C; Reilly D; Lowman H
    Structure; 1999 Feb; 7(2):157-68. PubMed ID: 10368283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a new interleukin-8 receptor in bovine species.
    Lahouassa H; Rainard P; Caraty A; Riollet C
    Mol Immunol; 2008 Feb; 45(4):1153-64. PubMed ID: 17727952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 receptor beta. The role of the carboxyl terminus in signal transduction.
    Ben-Baruch A; Bengali KM; Biragyn A; Johnston JJ; Wang JM; Kim J; Chuntharapai A; Michiel DF; Oppenheim JJ; Kelvin DJ
    J Biol Chem; 1995 Apr; 270(16):9121-8. PubMed ID: 7721826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing monoclonal antibodies to human IL-8 receptor A map to the NH2-terminal region of the receptor.
    Chuntharapai A; Lee J; Burnier J; Wood WI; Hébert C; Kim KJ
    J Immunol; 1994 Feb; 152(4):1783-9. PubMed ID: 8120387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-X-C chemokine receptor desensitization mediated through ligand-enhanced receptor phosphorylation on serine residues.
    Richmond A; Mueller S; White JR; Schraw W
    Methods Enzymol; 1997; 288():3-15. PubMed ID: 9356983
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemokine receptor-ligand interactions measured using time-resolved fluorescence.
    Inglese J; Samama P; Patel S; Burbaum J; Stroke IL; Appell KC
    Biochemistry; 1998 Feb; 37(8):2372-7. PubMed ID: 9485384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor.
    Zdanov A; Schalk-Hihi C; Wlodawer A
    Protein Sci; 1996 Oct; 5(10):1955-62. PubMed ID: 8897595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of the ternary complex of interleukin-10 with its soluble receptors.
    Pletnev S; Magracheva E; Wlodawer A; Zdanov A
    BMC Struct Biol; 2005 Jun; 5():10. PubMed ID: 15985167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the binding surface of interleukin-8 complexed with an N-terminal fragment of the type 1 human interleukin-8 receptor.
    Clubb RT; Omichinski JG; Clore GM; Gronenborn AM
    FEBS Lett; 1994 Jan; 338(1):93-7. PubMed ID: 8307164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Analysis of Chemokine Receptor-Ligand Interactions.
    Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
    J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function.
    Loetscher M; Amara A; Oberlin E; Brass N; Legler D; Loetscher P; D'Apuzzo M; Meese E; Rousset D; Virelizier JL; Baggiolini M; Arenzana-Seisdedos F; Moser B
    Curr Biol; 1997 Sep; 7(9):652-60. PubMed ID: 9285716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide.
    Olejniczak ET; Zhou MM; Fesik SW
    Biochemistry; 1997 Apr; 36(14):4118-24. PubMed ID: 9100005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the extracellular binding regions of the human interleukin-8 type B receptor.
    Katancik JA; Sharma A; Radel SJ; De Nardin E
    Biochem Biophys Res Commun; 1997 Mar; 232(3):663-8. PubMed ID: 9126332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family.
    Preimel D; Sticht H
    J Mol Model; 2004 Aug; 10(4):290-6. PubMed ID: 15243778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modeling study of the human interleukin-7 receptor complex.
    Kroemer RT; Richards WG
    Protein Eng; 1996 Dec; 9(12):1135-42. PubMed ID: 9010926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.
    Paterlini MG
    Biophys J; 2002 Dec; 83(6):3012-31. PubMed ID: 12496074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.
    Khandaker MH; Xu L; Rahimpour R; Mitchell G; DeVries ME; Pickering JG; Singhal SK; Feldman RD; Kelvin DJ
    J Immunol; 1998 Aug; 161(4):1930-8. PubMed ID: 9712063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
    Gerber N; Lowman H; Artis DR; Eigenbrot C
    Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.